{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T01:43:28Z","timestamp":1775526208052,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PT2020 UID\/QUI\/50006\/2013 - POCI\/01\/0145\/FEDER\/007265"],"award-info":[{"award-number":["PT2020 UID\/QUI\/50006\/2013 - POCI\/01\/0145\/FEDER\/007265"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s11095-020-02865-1","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:02:35Z","timestamp":1594666955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"37","author":[{"given":"R.G.R.","family":"Pinheiro","sequence":"first","affiliation":[]},{"given":"A.","family":"Granja","sequence":"additional","affiliation":[]},{"given":"J.A.","family":"Loureiro","sequence":"additional","affiliation":[]},{"given":"M.C.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"M.","family":"Pinheiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-5837","authenticated-orcid":false,"given":"A.R.","family":"Neves","sequence":"additional","affiliation":[]},{"given":"S.","family":"Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"2865_CR1","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1021\/jf049243r","volume":"52","author":"HJ Heoand","year":"2004","unstructured":"Heoand HJ, Lee CY. Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration. J Agric Food Chem. 2004;52:7514\u20137.","journal-title":"J Agric Food Chem"},{"key":"2865_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3892\/ijmm.2011.613","volume":"27","author":"ZJ Zhang","year":"2011","unstructured":"Zhang ZJ, Cheang LC, Wang MW, Lee SM. Quercetin exerts a neuroprotective effect through inhibition of the iNOS\/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish. Int J Mol Med. 2011;27:195\u2013203.","journal-title":"Int J Mol Med"},{"key":"2865_CR3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0006-8993(02)04150-1","volume":"965","author":"H Dok-Go","year":"2003","unstructured":"Dok-Go H, Lee KH, Kim HJ, Lee EH, Lee J, Song YS, et al. Neuroprotective effects of antioxidative flavonoids, quercetin, (+)-dihydroquercetin and quercetin 3-methyl ether, isolated from Opuntia ficus-indica var. saboten. Brain Res. 2003;965:130\u20136.","journal-title":"Brain Res"},{"key":"2865_CR4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1471-4159.2004.02563.x","volume":"90","author":"Y Sagara","year":"2004","unstructured":"Sagara Y, Vanhnasy J, Maher P. Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation. J Neurochem. 2004;90:1144\u201355.","journal-title":"J Neurochem"},{"key":"2865_CR5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00011-007-6172-9","volume":"56","author":"YD Min","year":"2007","unstructured":"Min YD, Choi CH, Bark H, Son HY, Park HH, Lee S, et al. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm Res: Official Journal of the European Histamine Research Society [et al]. 2007;56:210\u20135.","journal-title":"Inflamm Res: Official Journal of the European Histamine Research Society [et al]"},{"key":"2865_CR6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2222.2000.00768.x","volume":"30","author":"M Kimata","year":"2000","unstructured":"Kimata M, Shichijo M, Miura T, Serizawa I, Inagaki N, Nagai H. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy: J Br Soc Allergy Clin Immunol. 2000;30:501\u20138.","journal-title":"Clin Exp Allergy: J Br Soc Allergy Clin Immunol"},{"key":"2865_CR7","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/0006-2952(89)90410-3","volume":"38","author":"IB Afanas'ev","year":"1989","unstructured":"Afanas'ev IB, Dorozhko AI, Brodskii AV, Kostyuk VA, Potapovitch AI. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol. 1989;38:1763\u20139.","journal-title":"Biochem Pharmacol"},{"key":"2865_CR8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0006-2952(98)00102-6","volume":"56","author":"SA van Acker","year":"1998","unstructured":"van Acker SA, van Balen GP, van den Berg DJ, Bast A, van der Vijgh WJ. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem Pharmacol. 1998;56:935\u201343.","journal-title":"Biochem Pharmacol"},{"key":"2865_CR9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jnutbio.2008.03.002","volume":"20","author":"MA Ansari","year":"2009","unstructured":"Ansari MA, Abdul HM, Joshi G, Opii WO, Butterfield DA. Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer\u2019s disease. J Nutr Biochem. 2009;20:269\u201375.","journal-title":"J Nutr Biochem"},{"key":"2865_CR10","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1021\/jf051985c","volume":"53","author":"H Kim","year":"2005","unstructured":"Kim H, Park BS, Lee KG, Choi CY, Jang SS, Kim YH, et al. Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem. 2005;53:8537\u201341.","journal-title":"J Agric Food Chem"},{"key":"2865_CR11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuropharm.2015.01.027","volume":"93","author":"S-GA Maria","year":"2015","unstructured":"Maria S-GA, Ignacio M-MJ, Ram\u00edrez-Pineda Jose R, Marisol L-R, Edison O, Patricia C-GG. The flavonoid quercetin ameliorates Alzheimer\u2019s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer\u2019s disease model mice. Neuropharmacology. 2015;93:134\u201345.","journal-title":"Neuropharmacology."},{"key":"2865_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jnutbio.2014.10.008","volume":"26","author":"Y Guoand","year":"2015","unstructured":"Guoand Y, Bruno RS. Endogenous and exogenous mediators of quercetin bioavailability. J Nutr Biochem. 2015;26:201\u201310.","journal-title":"J Nutr Biochem"},{"key":"2865_CR13","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/1541-4337.12342","volume":"17","author":"AF Almeida","year":"2018","unstructured":"Almeida AF, Borge GIA, Piskula M, Tudose A, Tudoreanu L, Valentova K, et al. Bioavailability of quercetin in humans with a focus on interindividual variation. Compr Rev Food Sci Food Saf. 2018;17:714\u201331.","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"2865_CR14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.15171\/apb.2016.044","volume":"6","author":"S Soni","year":"2016","unstructured":"Soni S, Ruhela RK, Medhi B. Nanomedicine in central nervous system (CNS) disorders: a present and future prospective. Adv Pharm Bull. 2016;6:319\u201335.","journal-title":"Adv Pharm Bull"},{"key":"2865_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40089-017-0208-0","volume":"7","author":"A Chowdhury","year":"2017","unstructured":"Chowdhury A, Kunjiappan S, Panneerselvam T, Somasundaram B, Bhattacharjee C. Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases. Int Nano Lett. 2017;7:91\u2013122.","journal-title":"Int Nano Lett"},{"key":"2865_CR16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/neu.10153","volume":"53","author":"N Le Novere","year":"2002","unstructured":"Le Novere N, Corringer PJ, Changeux JP. The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol. 2002;53:447\u201356.","journal-title":"J Neurobiol"},{"key":"2865_CR17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","volume":"78","author":"C Gotti","year":"2009","unstructured":"Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I, et al. Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol. 2009;78:703\u201311.","journal-title":"Biochem Pharmacol"},{"key":"2865_CR18","doi-asserted-by":"crossref","first-page":"H212","DOI":"10.1152\/ajpheart.01210.2004","volume":"289","author":"BT Hawkins","year":"2005","unstructured":"Hawkins BT, Egleton RD, Davis TP. Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. Am J Physiol Heart Circ Physiol. 2005;289:H212\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2865_CR19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13550280590900427","volume":"11","author":"M Lafon","year":"2005","unstructured":"Lafon M. Rabies virus receptors. J Neurovirol. 2005;11:82\u20137.","journal-title":"J Neurovirol"},{"key":"2865_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","volume":"448","author":"P Kumar","year":"2007","unstructured":"Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL, et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature. 2007;448:39\u201343.","journal-title":"Nature."},{"key":"2865_CR21","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","volume":"30","author":"Y Liu","year":"2009","unstructured":"Liu Y, Huang R, Han L, Ke W, Shao K, Ye L, et al. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials. 2009;30:4195\u2013202.","journal-title":"Biomaterials."},{"key":"2865_CR22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2018.03.028","volume":"543","author":"HC Hua","year":"2018","unstructured":"Hua HC, Zhang XM, Mu HJ, Meng QQ, Jiang Y, Wang YY, et al. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy. Int J Pharm. 2018;543:179\u201389.","journal-title":"Int J Pharm"},{"key":"2865_CR23","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1021\/acsnano.7b08172","volume":"12","author":"LH You","year":"2018","unstructured":"You LH, Wang J, Liu TQ, Zhang YL, Han XX, Wang T, et al. Targeted brain delivery of rabies virus glycoprotein 29-modified deferoxamine-loaded nanoparticles reverses functional deficits in Parkinsonian mice. ACS Nano. 2018;12:4123\u201339.","journal-title":"ACS Nano"},{"key":"2865_CR24","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1021\/acs.molpharmaceut.7b00158","volume":"14","author":"M Oswald","year":"2017","unstructured":"Oswald M, Geissler S, Goepferich A. Targeting the central nervous system (CNS): a review of rabies virus-targeting strategies. Mol Pharm. 2017;14:2177\u201396.","journal-title":"Mol Pharm"},{"key":"2865_CR25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2217\/nnm.12.197","volume":"8","author":"AR Neves","year":"2013","unstructured":"Neves AR, Lucio M, Martins S, Lima JL, Reis S. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int J Nanomedicine. 2013;8:177\u201387.","journal-title":"Int J Nanomedicine"},{"key":"2865_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12951-016-0177-x","volume":"14","author":"AR Neves","year":"2016","unstructured":"Neves AR, Queiroz JF, Reis S. Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E. J Nanobiotechnol. 2016;14:27.","journal-title":"J Nanobiotechnol"},{"key":"2865_CR27","doi-asserted-by":"crossref","first-page":"495103","DOI":"10.1088\/0957-4484\/26\/49\/495103","volume":"26","author":"AR Neves","year":"2015","unstructured":"Neves AR, Queiroz JF, Weksler B, Romero IA, Couraud PO, Reis S. Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E. Nanotechnology. 2015;26:495103.","journal-title":"Nanotechnology."},{"key":"2865_CR28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/acs.bioconjchem.6b00705","volume":"28","author":"AR Neves","year":"2017","unstructured":"Neves AR, Queiroz JF, Lima SAC, Reis S. Apo E-functionalization of solid lipid nanoparticles enhances brain drug delivery: uptake mechanism and transport pathways. Bioconjug Chem. 2017;28:995\u20131004.","journal-title":"Bioconjug Chem"},{"key":"2865_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-8118-10-16","volume":"10","author":"B Weksler","year":"2013","unstructured":"Weksler B, Romero IA, Couraud PO. The hCMEC\/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS. 2013;10:16.","journal-title":"Fluids Barriers CNS"},{"key":"2865_CR30","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","volume":"19","author":"BB Weksler","year":"2005","unstructured":"Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J: Official Publication FASEB. 2005;19:1872\u20134.","journal-title":"FASEB J: Official Publication FASEB"},{"key":"2865_CR31","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2008.05730.x","volume":"107","author":"B Poller","year":"2008","unstructured":"Poller B, Gutmann H, Krahenbuhl S, Weksler B, Romero I, Couraud PO, et al. The human brain endothelial cell line hCMEC\/D3 as a human blood-brain barrier model for drug transport studies. J Neurochem. 2008;107:1358\u201368.","journal-title":"J Neurochem"},{"key":"2865_CR32","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1021\/la050472x","volume":"21","author":"R Sabateand","year":"2005","unstructured":"Sabateand R, Estelrich J. Stimulatory and inhibitory effects of alkyl bromide surfactants on beta-amyloid fibrillogenesis. Langmuir. 2005;21:6944\u20139.","journal-title":"Langmuir."},{"key":"2865_CR33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymeth.2004.03.012","volume":"34","author":"MR Nilsson","year":"2004","unstructured":"Nilsson MR. Techniques to study amyloid fibril formation in vitro. Methods. 2004;34:151\u201360.","journal-title":"Methods."},{"key":"2865_CR34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2009.01.090","volume":"380","author":"S Rocha","year":"2009","unstructured":"Rocha S, Cardoso I, Borner H, Pereira MC, Saraiva MJ, Coelho M. Design and biological activity of beta-sheet breaker peptide conjugates. Biochem Bioph Res Commun. 2009;380:397\u2013401.","journal-title":"Biochem Bioph Res Commun"},{"key":"2865_CR35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/cn300076x","volume":"3","author":"LP Jameson","year":"2012","unstructured":"Jameson LP, Smith NW, Dzyuba SV. Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (abeta) self-assembly. ACS Chem Neurosci. 2012;3:807\u201319.","journal-title":"ACS Chem Neurosci"},{"key":"2865_CR36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","volume":"2","author":"H LeVine 3rd","year":"1993","unstructured":"LeVine H 3rd. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993;2:404\u201310.","journal-title":"Protein Sci"},{"key":"2865_CR37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/mp400393a","volume":"11","author":"Z Yan","year":"2014","unstructured":"Yan Z, Yang Y, Wei X, Zhong J, Wei D, Liu L, et al. Tumor-penetrating peptide mediation: an effective strategy for improving the transport of liposomes in tumor tissue. Mol Pharm. 2014;11:218\u201325.","journal-title":"Mol Pharm"},{"key":"2865_CR38","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/mp500086e","volume":"11","author":"X Wei","year":"2014","unstructured":"Wei X, Zhan C, Chen X, Hou J, Xie C, Lu W. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery. Mol Pharm. 2014;11:3261\u20138.","journal-title":"Mol Pharm"},{"key":"2865_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2007.08.001","volume":"69","author":"M Gaumet","year":"2008","unstructured":"Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm: Official J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 2008;69:1\u20139.","journal-title":"Eur J Pharm Biopharm: Official J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV."},{"key":"2865_CR40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"N Naseri","year":"2015","unstructured":"Naseri N, Valizadeh H, Zakeri-Milani P. Solid lipid nanoparticles and nanostructured lipid carriers: structure. Prep Appl Adv Pharm Bull. 2015;5:305\u201313.","journal-title":"Prep Appl Adv Pharm Bull"},{"key":"2865_CR41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0939-6411(98)00074-5","volume":"47","author":"C Freitasand","year":"1999","unstructured":"Freitasand C, Muller RH. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur J Pharm Biopharm: Official J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 1999;47:125\u201332.","journal-title":"Eur J Pharm Biopharm: Official J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV"},{"key":"2865_CR42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0009-8981(73)90174-5","volume":"46","author":"JF Burdand","year":"1973","unstructured":"Burdand JF, Usategui-Gomez M. A colorimetric assay for serum lactate dehydrogenase. Clin Chim Acta; Int J Clin Chem. 1973;46:223\u20137.","journal-title":"Clin Chim Acta; Int J Clin Chem"},{"key":"2865_CR43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0022-1759(83)90438-6","volume":"64","author":"C Korzeniewskiand","year":"1983","unstructured":"Korzeniewskiand C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods. 1983;64:313\u201320.","journal-title":"J Immunol Methods"},{"key":"2865_CR44","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/pbi.12719","volume":"15","author":"W Phoolcharoen","year":"2017","unstructured":"Phoolcharoen W, Prehaud C, van Dolleweerd CJ, Both L, da Costa A, Lafon M, et al. Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device. Plant Biotechnol J. 2017;15:1331\u20139.","journal-title":"Plant Biotechnol J"},{"key":"2865_CR45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/psc.2535","volume":"19","author":"JA Loureiro","year":"2013","unstructured":"Loureiro JA, Rocha S, Pereira Mdo C. Charged surfactants induce a non-fibrillar aggregation pathway of amyloid-beta peptide. J Pept Sci: Official Publication Eur Pept Soc. 2013;19:581\u20137.","journal-title":"J Pept Sci: Official Publication Eur Pept Soc"},{"key":"2865_CR46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.colsurfb.2015.06.067","volume":"134","author":"JA Loureiro","year":"2015","unstructured":"Loureiro JA, Gomes B, Fricker G, Cardoso I, Ribeiro CA, Gaiteiro C, et al. Dual ligand immunoliposomes for drug delivery to the brain. Colloid Surface B, Biointerfaces. 2015;134:213\u20139.","journal-title":"Colloid Surface B, Biointerfaces"},{"key":"2865_CR47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/molecules22020277","volume":"22","author":"JA Loureiro","year":"2017","unstructured":"Loureiro JA, Andrade S, Duarte A, Neves AR, Queiroz JF, Nunes C, et al. Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer\u2019s disease. Molecules (Basel, Switzerland). 2017;22:277.","journal-title":"Molecules (Basel, Switzerland)"},{"key":"2865_CR48","doi-asserted-by":"crossref","first-page":"16742","DOI":"10.1073\/pnas.262663499","volume":"99","author":"AT Petkova","year":"2002","unstructured":"Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, et al. A structural model for Alzheimer\u2019s beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A. 2002;99:16742\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2865_CR49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1471-4159.1995.64010253.x","volume":"64","author":"CJ Pike","year":"1995","unstructured":"Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25\u201335 region to aggregation and neurotoxicity. J Neurochem. 1995;64:253\u201365.","journal-title":"J Neurochem"},{"key":"2865_CR50","doi-asserted-by":"crossref","first-page":"40810","DOI":"10.1074\/jbc.M205659200","volume":"277","author":"M Torok","year":"2002","unstructured":"Torok M, Milton S, Kayed R, Wu P, McIntire T, Glabe CG, et al. Structural and dynamic features of Alzheimer\u2019s Abeta peptide in amyloid fibrils studied by site-directed spin labeling. J Biol Chem. 2002;277:40810\u20135.","journal-title":"J Biol Chem"},{"key":"2865_CR51","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/S0006-3495(03)70057-5","volume":"84","author":"ON Antzutkin","year":"2003","unstructured":"Antzutkin ON, Balbach JJ, Tycko R. Site-specific identification of non-beta-strand conformations in Alzheimer\u2019s beta-amyloid fibrils by solid-state NMR. Biophys J. 2003;84:3326\u201335.","journal-title":"Biophys J"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02865-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-020-02865-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02865-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T23:39:26Z","timestamp":1626133166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-020-02865-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2865"],"URL":"https:\/\/doi.org\/10.1007\/s11095-020-02865-1","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"16 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"139"}}